Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shutaro Ishimura

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
American Journal of Hypertension|June 22, 2012
Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevationHideki Ota, Masato Furuhashi, Shutaro Ishimura, et al.
Plos One|November 27, 2013
Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general populationShutaro Ishimura, Masato Furuhashi, Yuki Watanabe, et al.
Lipids in Health and Disease|January 13, 2016
Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl estersMasato Furuhashi, Shinya Hiramitsu, Tomohiro Mita, et al.
Plos One|December 16, 2014
Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunctionYusuke Okazaki, Masato Furuhashi, Marenao Tanaka, et al.
Journal of Lipid Research|October 16, 2015
Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitusMasato Furuhashi, Shinya Hiramitsu, Tomohiro Mita, et al.
Obesity (Silver Spring, Md.)|December 19, 2014
FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanismsTomohiro Mita, Masato Furuhashi, Shinya Hiramitsu, et al.
American Journal of Hypertension|May 21, 2014
Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blockerMasato Furuhashi, Norihito Moniwa, Tomohiro Mita, et al.
Cardiovascular Diabetology|August 22, 2014
Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general populationTakahiro Fuseya, Masato Furuhashi, Satoshi Yuda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 2016
Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary AtherosclerosisMasato Furuhashi, Takahiro Fuseya, Masaki Murata, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
American Journal of Hypertension|June 22, 2012
Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevationHideki Ota, Masato Furuhashi, Shutaro Ishimura, et al.
Plos One|November 27, 2013
Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general populationShutaro Ishimura, Masato Furuhashi, Yuki Watanabe, et al.
Lipids in Health and Disease|January 13, 2016
Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl estersMasato Furuhashi, Shinya Hiramitsu, Tomohiro Mita, et al.
Plos One|December 16, 2014
Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunctionYusuke Okazaki, Masato Furuhashi, Marenao Tanaka, et al.
Journal of Lipid Research|October 16, 2015
Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitusMasato Furuhashi, Shinya Hiramitsu, Tomohiro Mita, et al.
Obesity (Silver Spring, Md.)|December 19, 2014
FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanismsTomohiro Mita, Masato Furuhashi, Shinya Hiramitsu, et al.
American Journal of Hypertension|May 21, 2014
Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blockerMasato Furuhashi, Norihito Moniwa, Tomohiro Mita, et al.
Cardiovascular Diabetology|August 22, 2014
Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general populationTakahiro Fuseya, Masato Furuhashi, Satoshi Yuda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 2016
Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary AtherosclerosisMasato Furuhashi, Takahiro Fuseya, Masaki Murata, et al.
Pageof 2